Clinical and Pharmacogenetic Influences on Response to Hydroxychloroquine in Discoid Lupus Erythematosus: A Retrospective Cohort Study
- 1 October 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 131 (10), 1981-1986
- https://doi.org/10.1038/jid.2011.167
Abstract
The recommended systemic therapy of choice for discoid lupus erythematosus (DLE) is the 4-aminoquinolone antimalarial hydroxychloroquine. There is limited published information on the likelihood of clinical response and, in particular, what factors influence outcome. We conducted a multicenter observational and pharmacogenetic study of 200 patients with DLE treated with hydroxychloroquine. The primary outcome was clinical response to hydroxychloroquine. We investigated the effects of disease attributes and metabolizing cytochrome P450 (CYP) polymorphisms on clinical outcome. Although the majority of patients responded to hydroxychloroquine, a significant proportion (39%) either failed to respond or was intolerant of the drug. Cigarette smoking and CYP genotype did not have any significant influence on response to hydroxychloroquine. Moreover, multivariate analysis indicated that disseminated disease (odds ratio (OR): 0.21; 95% confidence interval (CI): 0.08–0.52; PP=0.009) were significantly associated with lack of response to hydroxychloroquine. These findings suggest that baseline lupus severity and SLE are predictors of response to hydroxychloroquine. A prospective study is now required to further investigate the relationship between disease activity and response to hydroxychloroquine. This will have the potential to further inform the clinical management of this disfiguring photosensitive disease.Keywords
This publication has 21 references indexed in Scilit:
- Measuring disease activity and damage in discoid lupus erythematosusBritish Journal of Dermatology, 2010
- Cutaneous Lupus ErythematosusAmerican Journal of Clinical Dermatology, 2009
- Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patientsBritish Journal of Dermatology, 2009
- Cross-sectional Analysis of a Collaborative Web-Based Database for Lupus Erythematosus–Associated Skin LesionsArchives of Dermatology, 2009
- Lifetime prevalence distribution of chronic discoid lupus erythematosusJournal of the European Academy of Dermatology and Venereology, 2007
- Association between Discoid Lupus erythematosus and Cigarette SmokingDermatology, 2005
- Influence du tabagisme sur l'efficacité des antipaludéens de synthèse (APS) sur les lésions cutanées de sujets atteints de lupus : évaluation à travers une étude prospectiveLa Revue de Médecine Interne, 2004
- Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritisArthritis & Rheumatism, 2002
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Epidemiology and socioeconomic impact of skin disease in lupus erythematosusLupus, 1997